Provided by Tiger Fintech (Singapore) Pte. Ltd.

VistaGen Therapeutics

2.32
+0.08003.57%
Post-market: 2.320.00000.00%16:05 EDT
Volume:47.60K
Turnover:110.53K
Market Cap:66.96M
PE:-1.50
High:2.38
Open:2.30
Low:2.26
Close:2.24
Loading ...
Apr 26, 2021

Major Issues Report

8-K - Current report
Mar 23, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 22, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 05, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Major Issues Report

8-K - Current report
Feb 11, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 02, 2021

Major Issues Report

8-K - Current report
Jan 22, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 06, 2021

Major Issues Report

8-K - Current report
Jan 04, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Dec 22, 2020

Major Issues Report

8-K - Current report
Dec 18, 2020

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Dec 01, 2020

Major Issues Report

8-K - Current report
Nov 16, 2020

Major Issues Report

8-K - Current report
Nov 12, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 13, 2020

Major Issues Report

8-K - Current report
Sep 18, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals